Please provide your email address to receive an email when new articles are posted on . A majority of virologically suppressed patients with HIV considered long-acting injectable ART to be acceptable, ...
Long-acting cabotegravir/rilpivirine (Cabenuva; CAB/RPV-LA) appeared superior to daily oral antiretroviral therapy (ART) in maintaining viral load suppression for ...
Cabotegravir demonstrated efficacy as a long-acting PrEP, with no new HIV cases in the PILLAR trial over 12 months. The combination of cabotegravir and rilpivirine showed high viral suppression rates ...
Some German vaccination centres are offering patients an injection of art along with the coronavirus jab. In the Bavarian town of Straubing, 84 works by 42 local artists are on show in a vaccination ...
Some German vaccination centres are offering patients an injection of art along with the coronavirus jab. In the Bavarian town of Straubing, 84 works by 42 local artists are on show in a vaccination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback